Dillon & Associates Inc. Buys 216 Shares of Aflac Incorporated (NYSE:AFL)

Dillon & Associates Inc. raised its stake in Aflac Incorporated (NYSE:AFL) by 6.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,516 shares of the financial services provider’s stock after acquiring an additional 216 shares during the quarter. Dillon & Associates Inc.’s holdings in Aflac were worth $362,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Whipplewood Advisors LLC bought a new position in Aflac in the 4th quarter valued at approximately $26,000. BankPlus Trust Department bought a new position in Aflac in the 4th quarter valued at approximately $34,000. Raelipskie Partnership bought a new position in Aflac in the 3rd quarter valued at approximately $38,000. Curio Wealth LLC bought a new position in Aflac in the 4th quarter valued at approximately $36,000. Finally, OFI Invest Asset Management bought a new position in Aflac in the 4th quarter valued at approximately $38,000. Institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of AFL stock opened at $108.10 on Monday. The firm has a 50 day moving average of $105.95 and a 200-day moving average of $107.61. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The company has a market cap of $59.08 billion, a price-to-earnings ratio of 11.26, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, equities analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Insider Activity at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 55,546 shares of company stock valued at $5,863,616. 0.90% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

AFL has been the subject of a number of research reports. Piper Sandler dropped their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Wells Fargo & Company decreased their target price on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 19th. BMO Capital Markets began coverage on shares of Aflac in a research report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 target price for the company. Keefe, Bruyette & Woods decreased their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research report on Wednesday, February 12th. Finally, StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.